Kissei Pharmaceutical Co., Ltd.
64
4
6
54
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
6.3%
4 terminated/withdrawn out of 64 trials
93.1%
+6.6% vs industry average
48%
31 trials in Phase 3/4
26%
14 of 54 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (64)
A Late Phase II Clinical Trial of KDT-3594 in Patients With Parkinson's Disease
Role: lead
A Clinical Study of KLH-2109 in Patients With Endometriosis
Role: lead
A Clinical Study of MR13A9 in Hemodialysis Patients With Pruritus.
Role: lead
A Clinical Study of KLH-2109 in Uterine Fibroids Patient With Menorrhagia and Pain
Role: lead
A Phase III Clinical Study of MR13A9 in Hemodialysis Patients With Pruritus.
Role: lead
A Clinical Study in Patients With Chronic Idiopathic Thrombocytopenic Purpura in R788
Role: lead
Confirmatory Study 3 of KPS-0373 in Patients With Spinocerebellar Degeneration
Role: lead
Avacopan vs Reduced-dose Glucocorticoids in ANCA-associated Vasculitis
Role: collaborator
Efficacy and Safety of Linzagolix for the Treatment of Endometriosis-associated Pain.
Role: lead
Extension to Study on Efficacy and Safety of Linzagolix for the Treatment of Endometriosis-associated Pain (EDELWEISS 6)
Role: lead
Extension to Study on Efficacy and Safety of Linzagolix for the Treatment of Endometriosis-associated Pain
Role: lead
A Phase 3 Study to Confirm the Efficacy and Safety of Linzagolix to Treat Endometriosis-associated Pain
Role: lead
An Early Phase 2 Clinical Study of KSP-0243
Role: lead
A Clinical Study of KLH-2109 in Uterine Fibroids Patient With Menorrhagia
Role: lead
Special Drug Use-results Survey for Long-term Use（Avacopan）
Role: lead
Special Drug Use-results Survey for Long-term Use (Fostamatinib)
Role: lead
A Study to Evaluate the Safety and Efficacy of AJM300 in Participants With Active Ulcerative Colitis
Role: collaborator
A Clinical Study of KDT-3594 in Japanese Patients With Early Parkinson's Disease
Role: lead
A Clinical Study of KDT-3594 in Patients With Early Parkinson's Disease.
Role: lead
Clinical Study of YS110 in Patients With Malignant Pleural Mesothelioma
Role: lead